Cours Axis-Shield Ltd

Actions

Temps Différé London S.E. Autres places de cotation			Varia. 5j.	Varia. 1 janv.
- ^GBX	-.--%		-.--%	-.--%

Durée

Période

Style

Axis Shield : The Effect of Food Intake on the Pharmacokinetics of Vadadustat Following Single Dose Administration	29/07/20
Axis Shield : Randomized, Double-Blinded, Active-Controlled (Darbepoetin Alfa), Phase 3 Study of Vadadustat in Chronic Kidney Disease Patients With Anemia on Hemodialysis in Japan	29/07/20
Axis Shield : Preclinical Characterization of Vadadustat (AKB-6548), an Oral Small Molecule Hypoxia Inducible Factor Prolyl-4-Hydroxylase Inhibitor, for the Potential Treatment of Renal Anemia	29/07/20
Axis Shield : Targeted Literature Review of Patient-reported Burden of Anemia in Chronic Kidney Disease	29/07/20
Efficacy and Safety of Vadadustat, an Oral Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor, Being Evaluated for the Treatment of Anemia Due to Chronic Kidney Disease (CKD) in Japanese Subjects: Results from Phase 2 Studies (encore)	29/07/20

Axis-Shield Ltd est une société basée au Royaume-Uni. La société développe, fabrique et commercialise des produits de diagnostic in-vitro.

Secteur

	Varia. 1 janv.	Capi.
AXIS-SHIELD LTD	-.--%	0
BIOMÉRIEUX	-4,92%	12,27 Md
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	-5,82%	7,99 Md
DIASORIN S.P.A.	+5,43%	5,69 Md
LANTHEUS HOLDINGS, INC.	+26,16%	5,42 Md
AUTOBIO DIAGNOSTICS CO., LTD.	-9,58%	4,13 Md
10X GENOMICS, INC.	-59,63%	2,7 Md
ANDON HEALTH CO., LTD.	+8,44%	2,6 Md
VITROLIFE AB	-3,70%	2,38 Md
MYRIAD GENETICS, INC.	+21,00%	2,1 Md